News | October 04, 2021
Thermo Fisher opens biologics site in Lengnau, Switzerland
The state-of-the-art facility provides a pathway from development to large-scale biologics production
The state-of-the-art facility provides a pathway from development to large-scale biologics production
The 462,000 square foot state-of-the-art building targeting LEED Zero certification and is designed to be the most sustainable commercial lab building in Cambridge
The investment will increase SpeeDx internal capacity to scale up manufacturing
In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report
A high-value proposition recyclable film packed with industry-leading barrier and metal bond performance, sustainability quotient and U.S. FDA compliant
The company does not expect the outcome of this inspection to impact its plans
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland
In India, almost all approved vaccines are packed in FIOLAX glass made by SCHOTT
The country’s vaccine production has more than doubled since April and is set to touch 300 million doses next month
They enter into exclusive negotiations in a new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
Subscribe To Our Newsletter & Stay Updated
